Peptide News
A static news aggregator refreshed from FDA MedWatch, PubMed, and ClinicalTrials.gov so the site can surface real signal without inventing headlines.
Latest sync: Nov 7, 2026, 1:45 AM. This page favors official and public primary sources over generic news scraping.
Display order is chronological from newest to oldest; future-dated or recently indexed items are pushed to the end.
Status: live
Status: live
Status: live
Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis.
Rapid Commun Mass Spectrom • Retatrutide • Journal Article
What moved most recently
Newly surfaced trials, FDA action, and PubMed additions sorted with the newest items first.
Newest peptide and GLP-1 updates
A rolling stream of the most recent official and public-source items in the tracker. Future-dated PubMed indexing artifacts stay at the bottom.
Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis.
Rapid Commun Mass Spectrom • Retatrutide • Journal Article
Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity
RECRUITING • Yuzuncu Yil University
Validation & Intervention Testing for Aging, Longevity and Healthspan
NOT_YET_RECRUITING • The University of Texas Health Science Center at San Antonio
Lifestyle Counseling and Medication for Adolescent Weight Management
COMPLETED • University of Minnesota
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
RECRUITING • Pfizer
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
RECRUITING • Eli Lilly and Company
AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
RECRUITING • The First Affiliated Hospital of Anhui Medical University
Baseline monocyte GIP receptor mRNA expression is associated with reductions in body weight and FIB-4 index after switching to tirzepatide in patients with type 2 diabetes.
Diabetol Int • Tirzepatide • Journal Article
Investigational Peptides in Orthopaedic Practice: Evidence, Safety, and Patient Counseling for BPC-157, Thymosin Beta-4, and TB-500.
J Am Acad Orthop Surg • BPC-157 • Journal Article
Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues
SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resu
Pharmacy students' knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study.
Libyan J Med • Semaglutide • Journal Article
The pharmacotherapy for pediatric obesity: insights and challenges from adult weight-loss medications.
J Diabetes Metab Disord • Retatrutide • Journal Article
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
ACTIVE_NOT_RECRUITING • Eli Lilly and Company
Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety.
Acta Orthop Belg • BPC-157 • Journal Article
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RECRUITING • Eli Lilly and Company
Tirzepatide alleviates hepatic steatosis and inflammation in MASLD partly through suppression of macrophage Dectin-1/Syk/NF-κB signaling.
Eur J Pharmacol • Tirzepatide • Journal Article
GLP-1 receptor biology and the therapeutic role of incretin-based agonists in metabolic diseases.
Eur J Pharmacol • Retatrutide • Journal Article
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
ACTIVE_NOT_RECRUITING • Eli Lilly and Company
Possibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents-A Narrative Review.
Pharmaceuticals (Basel) • BPC-157 • Journal Article
Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review.
Sex Med Rev • Tesamorelin • Journal Article
Efficacy and Safety of Dual GLP-1/Glucagon Receptor Agonism in Overweight and Obesity: A Class-Specific Systematic Review and Meta-Analysis.
Diabetes Obes Metab • Retatrutide • Meta-Analysis
Food noise: A theoretical review.
Appetite • Tirzepatide • Journal Article
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
RECRUITING • Massachusetts General Hospital
Body Composition and Adipose Tissue in HIV
TERMINATED • Columbia University
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
RECRUITING • Hudson Biotech
FDA.gov
Regulatory and enforcement signal from FDA feeds that touch peptides, GLP-1s, compounding, and obesity.
ClinicalTrials.gov
Recently updated or newly visible clinical studies tied to tracked compounds and obesity-adjacent programs.
PubMed
Recent research hits for tracked peptide and GLP-1 terms, with reviews and meta-analyses surfaced when available.
This page is built from a generated JSON snapshot refreshed by scheduled syncs, not from a live browser request. FDA items come from RSS feeds, PubMed items come from NCBI utilities, and study updates come from the ClinicalTrials.gov API. The page is date-ordered for readability, while the underlying generator still scores relevance for homepage surfacing and future editorial modules.